Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Public ClinicalTrials.gov record NCT01542034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Study identification
- NCT ID
- NCT01542034
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Kythera Biopharmaceuticals
- Industry
- Enrollment
- 506 participants
Conditions and interventions
Conditions
Interventions
- Deoxycholic acid injection Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2012
- Primary completion
- Apr 30, 2013
- Completion
- Jul 31, 2013
- Last update posted
- Jun 14, 2015
2012 – 2013
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Birmingham | Alabama | 35205 | — |
| Investigational Site | Beverly Hills | California | 90210 | — |
| Investigational Site | Beverly Hills | California | 90212 | — |
| Investigational Site | Irvine | California | 92697 | — |
| Investigational Site | Los Angeles | California | 90201 | — |
| Investigational Site | Oceanside | California | 92056 | — |
| Investigational Site | San Diego | California | 92117 | — |
| Investigational Site | San Diego | California | 92121 | — |
| Investigational Site | New Haven | Connecticut | 06511 | — |
| Investigational Site | Washington D.C. | District of Columbia | 20037 | — |
| Investigational Site | Miami Beach | Florida | 33140 | — |
| Investigational Site | West Palm Beach | Florida | 33401 | — |
| Investigational Site | Atlanta | Georgia | 30342 | — |
| Investigational Site | Snellville | Georgia | 30078 | — |
| Investigational Site | Arlington | Illinois | 60005 | — |
| Investigational Site | Chicago | Illinois | 60611 | — |
| Investigational Site | Evansville | Indiana | 47713 | — |
| Investigational Site | Louisville | Kentucky | 40217 | — |
| Investigational Site | Glenn Dale | Maryland | 20769 | — |
| Investigational Site | Hunt Valley | Maryland | 21030 | — |
| Investigational Site | Rockville | Maryland | 20850 | — |
| Investigational Site | West Bloomfield | Michigan | 48322 | — |
| Investigational Site | Fridley | Minnesota | 55432 | — |
| Investigational Site | Omaha | Nebraska | 68144 | — |
| Investigational Site | New York | New York | 10028 | — |
| Investigational Site | New York | New York | 10029 | — |
| Investigational Site | Charlotte | North Carolina | 28207 | — |
| Investigational Site | Nashville | Tennessee | 37203 | — |
| Investigational Site | Nashville | Tennessee | 37215 | — |
| Investigational Site | Charlottesville | Virginia | 22911 | — |
| Investigational Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01542034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2015 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01542034 live on ClinicalTrials.gov.